Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Managers face a variety of challenges during their careers. Instead of falling into fight or flight, develop resilience to ...

After weeks of speculation, the question of surprise double 2024 Vuelta a España stage winner Pablo Castrillo's future team ...

Sharad Avasthi, from SMIFS, shares an in-depth analysis of the entire pharma sector, highlighting improved margins driven by price reductions in major markets like the U.S. He acknowledges that while ...

Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...

The pharmaceutical industry is poised for an 8.5% revenue growth, spurred by domestic formulations and niche US market ...

during the 6th CII Pharma & Life Sciences Summit 2024 today. He emphasized that the initiative has bolstered domestic ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

The recent article in The Atlantic that belittles subject matter experts advocating for holistic health and questioning the ...

Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has been testing it as an injectable form ...